Free Trial

IGC Pharma (IGC) SEC Filings & 10K Form

IGC Pharma logo
$0.33 +0.01 (+1.81%)
As of 10:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent IGC Pharma SEC Filings

DateFilerForm TypeView
09/27/2024
3:05 PM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM
IGC Pharma (Issuer)
Moran James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:23 PM
Bradbury Strategic Investment Fund A (0002022777) (Filed by)
IGC Pharma (Subject)
Form SC 13D/A
08/12/2024
8:26 AM
IGC Pharma (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:03 PM
IGC Pharma (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
1:38 PM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
1:17 PM
IGC Pharma (Filer)
Form DEFA14A
06/24/2024
12:32 PM
IGC Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEMKT:IGC) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners